CYTK - Company ID 0001061983
CYTOKINETICS INC (CYTK) reported revenue of $88.04M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $88.04M | +376.6% |
| FY 2024 | $18.47M | +145.3% |
| FY 2023 | $7.53M | -92.0% |
| FY 2022 | $94.59M | +34.3% |
| FY 2021 | $70.43M | +26.2% |
| FY 2020 | $55.83M | +107.8% |
| FY 2019 | $26.87M | -14.7% |
| FY 2018 | $31.50M | +135.6% |
| FY 2017 |
CYTOKINETICS INC (CYTK) reported revenue of $88.04M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2011 and fiscal 2025, CYTOKINETICS INC's revenue grew from $4.00M to $88.04M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $13.37M |
| -87.4% |
| FY 2016 | $106.41M | +271.3% |
| FY 2015 | $28.66M | -38.9% |
| FY 2014 | $46.94M | +53.2% |
| FY 2013 | $30.65M | +305.5% |
| FY 2012 | $7.56M | +89.0% |
| FY 2011 | $4.00M | - |